-
Developing the next generation of treatments requires multinational co-operation and co-ordination. Bronchiectasis has historically been a neglected "Orphan" disease. An international network will build capacity to perform high impact clinical trials and observational studies in bronchiectasis
-
EMBARC is multidisciplinary, bringing bronchiectasis specialists together with basic scientists, microbiologists, physiotherapists, specialist nurses and patients. Developing new treatments for bronchiectasis will require a better understanding of the pathophysiology and natural history of the disease.
-
Sharing expertise and research protocols around Europe. Help to build a wider network and grow clinical research capacity for bronchiectasis in Europe.
-
The European Bronchiectasis Registry is currently recruiting- help us reach the target of 10,000 patients!
-
The European Bronchiectasis Registry is supported by the European Union Innovative Medicines Initiative under the "New Drugs for Bad Bugs" programme, to help facilitate the development of new antibiotics against Gram-negative infections
-
Advancing research and improving clinical care for patients with non-cystic fibrosis bronchiectasis
-
EMBARC promotes awareness and clinical excellence in bronchiectasis care through educational events, courses and online resources.
-
EMBARC works with the European Respiratory Society and the national societies and networks around the world to promote co-operation, data sharing and clinical research in bronchiectasis
-
EMBARC is a European Respiratory Society clinical research collaboration, dedicated to encouraging participation from young and experienced researchers around Europe in the field of bronchiectasis
EMBARC is a pan-European network committed to promoting clinical research and education in bronchiectasis, through sharing of protocols, research idea and expertise. Central to this project is the creation of the European Bronchiectasis Registry, a collaboration open to all investigators around Europe caring for patients with bronchiectasis.
Latest News
EMBARC data to be presented at ERS 2016
Members of the EMBARC Network will be presenting registry data during the European Respiratory Society conference in London next month. We encourage everyone to join us on Sunday morning to see Dr …
Read More1st World Bronchiectasis Conference
EMBARC travel to Hannover today to attend the 1st World Bronchiectasis Conference in Germany. The conference is being held over three days in the newly restored historical Herrenhausen Palace and …
Read MoreEMBARC Publishes Bronchiectasis Research Priorities Roadmap
Now published online in the European Respiratory Journal, an EMBARC working group has published a list of 22 key recommendations for future research into bronchiectasis. This project involved a …
Read MoreLatest Research
Multidimensional severity assessment in bronchiectasis: an analysis of seven European cohorts.
Diagnostic challenges of bronchiectasis
Challenges in managing Pseudomonas aeruginosa in non-cystic fibrosis bronchiectasis
Recruitment
Join EMBARC
EMBARC is an open group and free to join.
For more information contact info@bronchiectasis.eu
Sign up at the registration page
| Talk to us on Twitter! |  |
| Connect with us on LinkedIn |  |
EMBARC AT ERS 2015
BRONCHIECTASIS CONFERENCE 2016
EMBARC invites you to attend the 1st World Bronchiectasis Conference which will be held over three days in The Herrenhausen Palace, Hannover.
